Taiwan FDA registration ddef3fa5dd6048a32a358adacba70cd4

Roche Cobas HSV 1 and 2 assays

TW: 羅氏可霸斯HSV 1和2檢驗試劑
Taiwan flagTaiwan·Risk Class 2·ROCHE MOLECULAR SYSTEMS, INC.·Registered Jun 22, 2015 – Jun 22, 2025Expired
Registration details
Analysis ID
ddef3fa5dd6048a32a358adacba70cd4
Customs Code
DHA05602735600
Company information
Manufacturer Country
United States
Authorized Representative
ROCHE DIAGNOSTICS LTD.
Product details
Intended Use
The Roche Cobas HSV 1 and 2 assays performed on the cobas 4800 system are automated, qualitative in vitro diagnostic tests. This test uses real-time PCR to directly detect and type herpes simplex virus types 1 and 2 (HSV-I and HSV-2) DNA in samples of anogenital lesions taken by clinicians from symptomatic male and female patients. The purpose of the Roche Cabas HSV 1 and 2 tests is to assist in the diagnosis of anogenital HSV-1 and HSV-2 infections in symptomatic patients.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.3305 Seroanalysis of monoperiasis virus
Import Information
import
Dates and status
Registration Date
Jun 22, 2015
Expiry Date
Jun 22, 2025
About this record

Access comprehensive regulatory information for Roche Cobas HSV 1 and 2 assays in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ddef3fa5dd6048a32a358adacba70cd4 and manufactured by ROCHE MOLECULAR SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices